» Articles » PMID: 29545260

Involvement of B Cells, Immunoglobulins, and Syk in the Pathogenesis of Abdominal Aortic Aneurysm

Abstract

Background: Abdominal aortic aneurysm (AAA) is a potentially life-threatening disease that is common in older individuals. Currently, therapeutic options are limited to surgical interventions. Although it has long been known that AAA tissue is enriched in B cells and immunoglobulins, their involvement in AAA pathogenesis remains controversial.

Methods And Results: We investigated the role of B cells and immunoglobulins in a murine model of AAA, induced with a periaortic application of CaCl, and in human AAA. Both human and mouse AAA tissue showed B-cell infiltration. Mouse AAA tissue showed deposition of IgG and activation of Syk, a key molecule in B-cell activation and immunoglobulin function, which were localized to infiltrating cells including B cells and macrophages. B-cell-deficient muMT mice showed suppression of AAA development that was associated with reduced activation of Syk and less expression of matrix metalloproteinase-9. Administration of exogenous immunoglobulins restored the blunted Syk activation and AAA development in muMT mice. Additionally, exogenous immunoglobulins induced interleukin-6 and metalloproteinase-9 secretions in human AAA tissue cultures. Furthermore, administration of R788, a specific Syk inhibitor, suppressed AAA expansion, reduced inflammatory response, and reduced immunoglobulin deposition in AAA tissue.

Conclusions: From these results, we concluded that B cells and immunoglobulins participated in AAA pathogenesis by promoting inflammatory and tissue-destructive activities. Finally, we identified Syk as a potential therapeutic target.

Citing Articles

Abdominal Aortic Aneurysm and PET/CT: From Molecular Mechanisms to Potential Molecular Imaging Targets.

Li C, Liu Z, Yuan G, Liu Y, Wang W Rev Cardiovasc Med. 2024; 24(5):132.

PMID: 39076752 PMC: 11273052. DOI: 10.31083/j.rcm2405132.


Differentiation between descending thoracic aortic diseases using machine learning and plasma proteomic signatures.

Momenzadeh A, Kreimer S, Guo D, Ayres M, Berman D, Chyu K Clin Proteomics. 2024; 21(1):38.

PMID: 38825704 PMC: 11145886. DOI: 10.1186/s12014-024-09487-4.


Application and challenges of TCR and BCR sequencing to investigate T- and B-cell clonality in elastase-induced experimental murine abdominal aortic aneurysm.

Elster C, Ommer-Blasius M, Lang A, Vajen T, Pfeiler S, Feige M Front Cardiovasc Med. 2023; 10:1221620.

PMID: 38034381 PMC: 10686233. DOI: 10.3389/fcvm.2023.1221620.


Differentiation between Descending Thoracic Aortic Diseases using Machine Learning and Plasma Proteomic Signatures.

Momenzadeh A, Kreimer S, Guo D, Ayres M, Berman D, Chyu K bioRxiv. 2023; .

PMID: 37162892 PMC: 10168345. DOI: 10.1101/2023.04.26.538468.


The role of long non-coding RNA in abdominal aortic aneurysm.

Xu Y, Yang S, Xue G Front Genet. 2023; 14:1153899.

PMID: 37007957 PMC: 10050724. DOI: 10.3389/fgene.2023.1153899.


References
1.
Schaheen B, Downs E, Serbulea V, Almenara C, Spinosa M, Su G . B-Cell Depletion Promotes Aortic Infiltration of Immunosuppressive Cells and Is Protective of Experimental Aortic Aneurysm. Arterioscler Thromb Vasc Biol. 2016; 36(11):2191-2202. PMC: 5083246. DOI: 10.1161/ATVBAHA.116.307559. View

2.
Guessous I, Periard D, Lorenzetti D, Cornuz J, Ghali W . The efficacy of pharmacotherapy for decreasing the expansion rate of abdominal aortic aneurysms: a systematic review and meta-analysis. PLoS One. 2008; 3(3):e1895. PMC: 2267254. DOI: 10.1371/journal.pone.0001895. View

3.
Aoki H, Yoshimura K, Matsuzaki M . Turning back the clock: regression of abdominal aortic aneurysms via pharmacotherapy. J Mol Med (Berl). 2007; 85(10):1077-88. DOI: 10.1007/s00109-007-0213-2. View

4.
Emeto T, Seto S, Golledge J . Targets for medical therapy to limit abdominal aortic aneurysm progression. Curr Drug Targets. 2014; 15(9):860-73. DOI: 10.2174/1389450115666140804155036. View

5.
Zhou H, Yan H, Bertram P, Hu Y, Springer L, Thompson R . Fibrinogen-specific antibody induces abdominal aortic aneurysm in mice through complement lectin pathway activation. Proc Natl Acad Sci U S A. 2013; 110(46):E4335-44. PMC: 3831981. DOI: 10.1073/pnas.1315512110. View